AgentFly Technologies is among companies participating in the SAFIR-Med demonstration flights due to take place on 7 April 2022 at DronePort in Sint-Truiden, Belgium. The half day show case event brings together the medical and aviation sectors in a show case event involving presentations and demonstration flights.
AgentFly Technologies develops simulation to assess airspace capacity. The company’s technology will support the real-world flights by helping to setup simulation parameters and scale-up correctly.
The aim of the event is to demonstrate how the SAFIR-Med project advances European U-space achieving safe, sustainable, socially accepted and socially beneficial urban air mobility. With the impulse from COVID-19 and EU drone legislation, the landscape is changing in favour of medical drones. This will showcase how is our society getting closer to bringing medical UAM to cities and their citizens. SAFIR-Med partners will present and demonstrate various medical use cases, as well as a set of UAM indicators that enable UAM impact assessment and finally several new technologies developed in the project. The trial flights will demonstrate the transport of human tissue and/or biological lab samples and medicine, an operation with a drone carrying an automated external defibrillator, and a patient transport operation.
For more information visit:
www.agentfly.com
